Cargando…

Outcomes of hysterectomy in HIV-seropositive women compared to seronegative women.

OBJECTIVE: To compare the postoperative complication rates after hysterectomy between HIV-infected patients and HIV-uninfected patients. STUDY DESIGN: We conducted a retrospective study of 24 human immunodeficiency virus-infected patients who underwent hysterectomy between January 1, 2000 and April...

Descripción completa

Detalles Bibliográficos
Autores principales: Franz, Jennifer, Jamieson, Denise J, Randall, Hugh, Spann, Cyril
Formato: Texto
Lenguaje:English
Publicado: 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784566/
https://www.ncbi.nlm.nih.gov/pubmed/16126502
http://dx.doi.org/10.1080/10647440500147901
Descripción
Sumario:OBJECTIVE: To compare the postoperative complication rates after hysterectomy between HIV-infected patients and HIV-uninfected patients. STUDY DESIGN: We conducted a retrospective study of 24 human immunodeficiency virus-infected patients who underwent hysterectomy between January 1, 2000 and April 2, 2003 at Grady Memorial Hospital. Postoperative complications rates among HIV-infected women were compared to those rates among HIV-uninfected women. Data were analyzed t-tests for continuous variables and chi-squared tests for categorical variables. RESULTS: The HIV-infected women were more likely to report smoking and recreational drug use. In addition, a higher proportion of the HIV-infected women were co-infected with hepatitis, with more than one-quarter of HIV-infected women being hepatitis B or C seropositive. Although the study was limited due to small sample size, no significant differences in complication rates were found among HIV-infected women compared with uninfected women. CONCLUSION: As HIV-infected women are living longer, healthier lives we anticipate that increased numbers of HIV-infected women will be undergoing hysterectomy for benign gynecologic conditions. It will be important, therefore, to carefully document any potential differences in operative risks.